Blueprint Medicines (BPMC) Scheduled to Post Quarterly Earnings on Thursday

Blueprint Medicines (NASDAQ:BPMC – Get Rating) is scheduled to announce its earnings results before the market opens on Thursday, May 4th. Analysts expect the company to announce earnings of ($2.61) per share for the quarter. Parties that are interested in registering for the company’s conference call can do so using this link. Blueprint Medicines (NASDAQ:BPMC […]

Related Keywords

Hong Kong ,Cambridge ,Cambridgeshire ,United Kingdom ,Traceyl Mccain ,Chris Varma ,Stifel Nicolaus ,Brian Druker ,Jeffreyw Albers ,Nicholasb Lydon ,Lazard Asset Management ,Morgan Stanley ,Blueprint Medicines Corp ,Wells Fargo Company ,Affinity Asset Advisors ,Blueprint Medicines Company Profile ,Hong Kong Ltd ,Blueprint Medicines ,Get Rating ,Director Jeffrey ,Asset Management ,Asset Advisors ,State Equity Partners ,Kong Ltd ,Alexis Borisy ,Blueprint Medicines Daily ,Nasdaq Bpmc ,Bpmc ,Medical ,Earnings ,